large stockpiles of covid vaccines will make matters worse



UMMATIMES - Olivier Wouters, a Disease expert from the London School of Economics and Political Science (LSE), UK, after seeing the practice of large-scale stockpiling of vaccines in rich countries which would make things worse.

"The stark reality is that the world now needs more doses of the Covid-19 vaccine than any other vaccine in history to immunize enough people to achieve global vaccine immunity," "If vaccines are not distributed more equitably, it may take years before the virus. Corona can be controlled at the global level. " said Olivier Wouters, Saturday (13/2).

Olivier Wouters revealed, until now there are still many low-income countries that have difficulty getting access to the covid-19 vaccine. In fact, there are already more than two dozen covid-19 vaccines, both vaccines in development and approved for use. this is caused by a number of things ranging from a lack of funds to purchase vaccines, to adequate infrastructure to transport and store vaccines that require special handling. Especially mRNA vaccines, which must be stored in a very cold place during delivery.

From the results of Olivier Wouters' research looking at data on vaccine sales globally, rich countries have secured 70 percent of the Covid-19 vaccine doses. This amount is even enough to vaccinate their population many times over.

"Securing vaccines in large numbers like this means a rich country prioritizing mass vaccination of its own population over considering vaccinations for health care workers and high-risk communities in poor countries," said Olivier Wouters.

Olivier Wouters asked vaccine manufacturers to accelerate the transfer of technology to developing countries to help them produce vaccines domestically and to control the soaring price of vaccines on the market.

So far the vaccines produced by China, India and Russia have been approved by the World Health Organization (WHO). This vaccine can be a big help for poor countries, considered to be simpler storage than vaccines made in the United States and Europe.